Single Dose Therapy of Zoledronic Acid for the Treatment of Transient Osteoporosis of Hip [PDF]
Annals of Rehabilitation Medicine, 2019 Objective To shorten the natural course of transient osteoporosis of hip (TOH), which is a self-limiting idiopathic condition and requires 6–12 months for the resolution of symptoms, various therapies including treatment with bisphosphonates have been ...
Sanjay Agarwala, Mayank Vijayvargiya
doaj +1 more source
Treatment of hypercalcaemia in thyrotoxicosis with aminohydroxypropylidene diphosphonate [PDF]
Postgraduate Medical Journal, 1988 Summary Two patients had symptomatic hypercalcaemia accompanying thyrotoxicosis, despite initial treatment with volume repletion, beta blockade and antithyroid drugs. They were further managed with intravenous infusions of aminohydroxypropylidene diphosphonate resulting in rapid normalization of the serum calcium, with relief of symptoms.
A. A. Alzaid +5 more
openaire +3 more sources
The effects of diphosphonates on the growth and glycolysis of connective-tissue cells in culture.
Biochemical Journal, 1978 1. The effects of two diphosphonates (compounds containing a P-C-P bond), disodium dichloromethanediphosphonate and disodium 1-hydroxyethane-1,1-diphosphonate, on the metabolism of cultured rat calvaria cells, rabbit ear cartilage cells and rat skin ...
D. Fast +4 more
semanticscholar +1 more source
Amiloidosi da transtiretina (ATTR): l’altra faccia della medaglia
Giornale di Clinica Nefrologia e Dialisi, 2019 Transthyretin amyloidosis (ATTR) is becoming an emerging clinical entity, and is currently the most common form of systemic amyloidosis. ATTR consists of two distinct diseases depending on whether the amyloid fibrils derive from the intact molecule of ...
Federico Perfetto +7 more
doaj +1 more source
Physicians' perspectives on the treatment of osteoporosis patients with bisphosphonates
Clinical Interventions in Aging, 2016 Tao Gu,1 Debra F Eisenberg Lawrence,1 Judith J Stephenson,1 Jingbo Yu2 1HealthCore, Wilmington, DE, 2Merck & Co., Inc., Kenilworth, NJ, USA Background: Noncompliance with bisphosphonate therapy among osteoporosis patients attenuates the reduction ...
Gu T +3 more
doaj
Response of a co-culture model of epithelial cells and gingival fibroblasts to zoledronic acid
Brazilian Oral ResearchOsteonecrosis of the jaw is an adverse effect of bisphosphonates. While the etiopathogenesis of this condition has been investigated, the interactions and effects of bisphosphonates on oral mucosa cells remain unclear.
Fernanda Gonçalves BASSO +6 more
doaj +1 more source
In vitro study: binding of 99mTc-DPD to synthetic amyloid fibrils
Current Issues in Pharmacy and Medical Sciences, 2015 This paper is an report of the investigation of the in vitro binding of 99mTc-DPD for synthetic amyloid fibrils used for the diagnosis of cardiac amyloidosis (CA), as compared with the use of 99mTc-HMDP and 99mTc-PPI. It also includes an inquiry into the
Buroni Federica E +4 more
doaj +1 more source
Osteoporosi: la malattia e il suo costo sanitario
Farmeconomia: Health Economics and Therapeutic Pathways, 2002 Osteoporosis is a disorder of bone re-modeling, characterized by loss of its micro-architecture and decreased bone density, which lead to fragility and high risk of fracture following moderate traumata.
Gianpaolo Zara +3 more
doaj +1 more source
TREATMENT OF MYOSITIS OSSIFICANS PROGRESSIVA WITH A DIPHOSPHONATE
The Lancet, 1972 Abstract The diphosphonate, disodium etidronate (ethane-1-hydroxy-1,1-diphosphonate, 'EHDP'), a compound known to inhibit the crystal growth of hydroxyapatite and to prevent ectopic calcification in experimental animals, has been given to two women with myositis ossificans progressiva.
Roslin Russell +4 more
openaire +4 more sources
Solvent Extraction of Inorganic Nitrates with Diphosphonate Ester. I. Zirconium, Yttrium and Lanthanide Nitrates [PDF]
, 1961 Hideo Saisho
openalex +1 more source